Dr. Seung Tae Lee, MD

Dr. Lee practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Lee's NPI, 1710284393, was assigned on February 17, 2011. Dr. Lee holds Maryland license D79526.

Dr. Lee's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Lee's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Lee is also affiliated with University of Maryland Capital Region Medical Center. The medical group on file is University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Lee's licenses on file in 2 states: Maryland and Texas.

CMS data shows 1,001 Medicare services from Dr. Lee across 10 procedure codes in 2024, for 187 Medicare patients. Medicare paid $76,500 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 68, with 44% women.

In 2024, Dr. Lee wrote 444 Medicare Part D claims for 62 patients. 64% of them were for generic drugs. CMS names the drug for 278 of them, across 10 drugs with 11 or more claims each, at $1,817,896 in total drug cost. In 2023, CMS named 287 claims across 13 drugs.

Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Lee from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $108.